Status:
TERMINATED
ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain
Lead Sponsor:
Nicholas Schott
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
Comparison of standard post-operative cesarean surgery pain management with regional post-op pain control.
Detailed Description
The purpose of this trial is to determine the efficacy of a postoperative analgesia strategy that incorporates quadratus lumborum block (QLB) in conjunction with a multi-modal post-cesarean analgesia ...
Eligibility Criteria
Inclusion
- Elective cesarean planned under spinal anesthesia
- Singleton pregnancy
- American Society of Anesthesiologists (ASA) classification score of 2 (or less)
- Gestational age of at least 37 weeks
- Intention to breastfeed infant
Exclusion
- Contraindications to neuraxial blockade (such as clinically relevant coagulopathy, recent anticoagulant use, patient refusal, or localized skin infection overlying the site of needle entry)
- Anatomical abnormalities contraindicating spinal or QLB placement
- Received/Conversion to general anesthesia
- Received supplemental parenteral anesthesia (sedation) for any reason (e.g. unanticipated prolonged surgical procedure)
- History of chronic pain
- History of chronic opioid use/abuse
- History of Subutex, methadone, other maintenance therapy
Key Trial Info
Start Date :
September 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2022
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03261193
Start Date
September 5 2017
End Date
November 11 2022
Last Update
May 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magee Women's Hospital of UPMC
Pittsburgh, Pennsylvania, United States, 15213